ICOSAVAX, INC. Stock-Based Compensation
ICOSAVAX, INC. reported Stock-Based Compensation of $18.91 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2023-11-14
- ICOSAVAX, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $6.60M, a 21.49% increase year-over-year.
- ICOSAVAX, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $6.31M, a 13.67% increase year-over-year.
- ICOSAVAX, INC. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $6.00M, a 31.87% increase year-over-year.
- ICOSAVAX, INC. share-based payment arrangement, noncash expense for the quarter ending 2022-12-31 was $6.16M, a 67.47% increase year-over-year.
- ICOSAVAX, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $21.69M, a 25.27% decline from fiscal 2021.
- ICOSAVAX, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $29.03M, a 11196.11% increase from fiscal 2020.
- ICOSAVAX, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $257.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $12.91M derived: sum of 2 quarters · filed 2023-11-14 | $18.91M 10-Q · filed 2023-11-14 | $25.07M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $6.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $12.31M 10-Q · filed 2023-08-14 | $18.47M derived: sum of 3 quarters · filed 2023-08-14 | $23.90M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | $6.00M 10-Q · filed 2023-05-10 | $12.16M derived: sum of 2 quarters · filed 2023-05-10 | $17.59M derived: sum of 3 quarters · filed 2023-11-14 | $23.14M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | $6.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $11.59M derived: sum of 2 quarters · filed 2023-11-14 | $17.14M derived: sum of 3 quarters · filed 2023-11-14 | $21.69M 10-K · filed 2023-03-30 |
| 2022-09-30 | $5.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $10.99M derived: sum of 2 quarters · filed 2023-11-14 | $15.54M 10-Q · filed 2023-11-14 | $19.21M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $5.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $10.10M 10-Q · filed 2023-08-14 | $13.78M derived: sum of 3 quarters · filed 2023-08-14 | $37.45M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $4.55M 10-Q · filed 2023-05-10 | $8.23M derived: sum of 2 quarters · filed 2023-05-10 | $31.90M derived: sum of 3 quarters · filed 2023-05-10 | $33.30M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $27.35M derived: sum of 2 quarters · filed 2023-03-30 | $28.75M derived: sum of 3 quarters · filed 2023-03-30 | $29.03M 10-K · filed 2023-03-30 |
| 2021-09-30 | $23.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $25.08M derived: sum of 2 quarters · filed 2022-11-14 | $25.35M 10-Q · filed 2022-11-14 | $25.42M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.68M 10-Q · filed 2022-08-15 | $1.75M derived: sum of 3 quarters · filed 2022-08-15 | $1.82M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $276.00K 10-Q · filed 2022-05-16 | $346.00K derived: sum of 2 quarters · filed 2022-05-16 | $416.00K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $140.00K derived: sum of 2 quarters · filed 2022-03-30 | $257.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $187.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $117.00K 10-Q · filed 2021-09-13 |